Search Results - "Bogdany, Jennifer"

Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression by REED, J. A, LOGANZO, F. JR, ALBINO, A. P, SHEA, C. R, WALKER, G. J, FLORES, J. F, GLENDENING, J. M, BOGDANY, J. K, SHEIL, M. J, HALUSKA, F. G, FOUNTAIN, J. W

“…Sporadic and familial malignant melanoma susceptibility has been linked to defects in the chromosomal region 9p21. Recently, a putative 9p21 tumor suppressor…”
Get full text

Axis I psychopathology in individuals with traumatic brain injury by Hibbard, M R, Uysal, S, Kepler, K, Bogdany, J, Silver, J

“…To assess the incidence, comorbidity, and patterns of resolution of DSM-IV mood, anxiety, and substance use disorders in individuals with traumatic brain…”
Get more information

Axis II psychopathology in individuals with traumatic brain injury by Hibbard, Mary. R., Bogdany, Jennifer, Uysal, Suzan, Kepler, Karen, Silver, Jonathan M., Gordon, Wayne A., Haddad, Lisa

“…Primary objectives:To determine the frequency and nature of post-TBI personality disorders (PDs) in a community-based sample of individuals with TBI. Research…”
Get full text

Axis II psychopathology in individuals with traumatic brain injury by Hibbard, Mary R., Bogdany, Jennifer, Uysal, Suzan, Kepler, Karen, Silver, Jonathan M., Gordon, Wayne A., Haddad, Lisa

Get full text

The Beck Depression Inventory: is it a suitable measure of depression for individuals with traumatic brain injury? by Sliwinski, M, Gordon, W A, Bogdany, J

“…This study examined the relationship between Beck Depression Inventory (BDI) scores and current diagnosis of depression, based on The Structured Clinical…”
Get more information

Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression by Reed, J A, McNutt, N S, Bogdany, J K, Albino, A P

“…The molecular events responsible for tumor progression in human cutaneous malignant melanoma remain unclear; however, critical to the process is the…”
Get more information

p53 expression is rare in cutaneous melanomas by Saenz-Santamaría, M C, McNutt, N S, Bogdany, J K, Shea, C R

“…Alterations in the tumor-suppressor gene p53 are common in many types of human malignancies, but the potential role of p53 in the pathogenesis of cutaneous…”
Get more information

Expression of p53 protein in human middle ear cholesteatomas : Pathogenetic implications by ALBINO, A. P, REED, J. A, BOGDANY, J. K, SASSOON, J, DESLOGE, R. B, PARISIER, S. C

“…Cholesteatoma is a destructive lesion of the middle ear or mastoid process or both. The molecular and cellular defects that result in the clinical hallmarks of…”
Get full text

Differential expression of CD44 in malignant cutaneous epithelial neoplasms by Prieto, V G, Reed, J A, McNutt, N S, Bogdany, J K, Lugo, J, Shea, C R

“…The CD44 antigen (ECMRIII, Hermes antigen) is a highly glycosylated cell-surface polypeptide involved in diverse cellular functions, including cell adhesion…”
Get more information

Increased numbers of mast cells in human middle ear cholesteatomas : Implications for treatment by ALBINO, A. P, REED, J. A, BOGDANY, J. K, SASSOON, J, PARISIER, S. C

“…Because many of the biologic phenomena in which mast cells are involved also are observed in human cholesteatoma pathology, the authors hypothesized that mast…”
Get full text